Suchergebnisse - "Nagashima, Hiromi"

PubPharm (40)

1

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

enthalten in: The New England journal of medicine | 2023

von Zhou, C. | Tang, K. | Cho, B. | +126

CommentIn: Cancer Discov. 2023 Dec 12;13(12):OF9. - PMID 37878779

2

A randomized trial to evaluate the preventive effect of lafutidine on chemotherapy-induced peripheral neuropathy in patients treated with carboplatin and paclitaxel for lung cancer

enthalten in: Annals of palliative medicine | 2023

von Cho, K. | Saikawa, H. | Hashimoto, T. | +9

3

Characteristics and prognostic analysis of patients with detected KRAS mutations in resected lung adenocarcinomas by peptide nucleic acid-locked nucleic acid polymerase chain reaction (PNA-LNA PCR) clamp method

enthalten in: Translational lung cancer research | 2023

von Hashimoto, T. | Owada, Y. | Katagiri, H. | +12

4

High level of C-reactive protein as a predictive factor for immune-related adverse events of immune checkpoint inhibitors in non-small cell lung cancer : a retrospective study

enthalten in: Journal of thoracic disease | 2023

von Onodera, R. | Chiba, S. | Nihei, S. | +6

5

Monitoring of Plasma EGFR Mutations during Osimertinib Treatment for NSCLC Patients with Acquired T790M Mutation

enthalten in: Cancers | 2023

von Watanabe, K. | Saito, R. | Miyauchi, E. | +7

6

Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS : An advanced medicine A trial

enthalten in: Cancer science | 2023

von Fujita, K. | Arai, R. | Shoji, S. | +23

7

A Case of Mediastinal Tuberculous Lymphadenitis in a Chronic Dialysis Patient Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA)

enthalten in: Medicina (Kaunas, Lithuania) | 2023

von Nagashima, H. | Abe, K. | Owada, Y. | +7

8

Combination treatment with bevacizumab plus erlotinib for meningeal carcinomatosis of afatinib-resistant EGFR mutated lung cancer without T790M mutation : a case report

enthalten in: Annals of palliative medicine | 2022

von Chiba, S. | Akiyama, M. | Yakuwa, K. | +6

9

Treatment with immune checkpoint inhibitors after EGFR-TKIs in EGFR-mutated lung cancer

enthalten in: Thoracic cancer | 2022

von Ito, T. | Nagashima, H. | Akiyama, M. | +9

10

Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026) : overall survival analysis of an open-label, randomised, multicentre, phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Kawashima, Y. | Fukuhara, T. | Saito, H. | +23